Association of Lipoprotein(a) Concentrations and Apolipoprotein(a) isoform with Coronary Artery Disease Stratification in Han Chinese

被引:0
|
作者
Song, Xijing [1 ]
Sun, Huidi [1 ]
Chen, Keping [1 ,2 ]
机构
[1] Southeast Univ, Zhongda Hosp, Sch Med, Clin Lab, Nanjing, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Sch Med, Dingjiaqiao Rd 87, Nanjing 210009, Peoples R China
关键词
coronary artery disease (CAD); Lp(a) concentrations; apo(a) isoform; Han Chinese; HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK; SIZE; MANAGEMENT; SEVERITY; NUMBER;
D O I
10.7754/Clin.Lab.2022.211232)
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The purpose of this study was to investigate the association between lipoprotein(a) [Lp(a)] concen-trations, apolipoprotein(a) [apo(a)] isoform, and coronary artery disease (CAD) stratification in Han Chinese.Methods: Logistic regression analysis was performed to analyze the association between Lp(a) concentrations, apo(a) isoform and CAD stratification. Lp(a) concentrations and apo(a) isoforms were combined with other risk factors to establish the optimal prediction model of CAD risk.Results: Individuals with the top quarter of Lp(a) concentrations had more than a two-fold higher risk of stable CAD and three-fold higher risk of acute coronary syndrome (ACS) compared with those in the bottom quarter. This association was no longer significant after adjustment for apo(a) isoforms in stable CAD (OR 2.198, 95% CI 0.991 -4.875, p = 0.053), but remained significant in the ACS (OR 3.583, 95% CI 1.278 -5.614, p < 0.05). Individu-als with small apo(a) isoforms had more than a two-fold higher risk of stable CAD and almost three-fold higher risk of ACS compared with those carrying larger apo(a) isoforms; however, this association was significantly alle-viated after adjustment for Lp(a) concentrations (OR 2.133, 95% CI 0.964 -4.742, p = 0.098; OR 2.642, 95% CI 1.032 -5.833, p = 0.298, respectively). A combination of Lp(a) concentrations and apo(a) isoforms with other risk factors was the optimal prediction model of CAD risk (AUC 0.800, 95% CI 0.752 -0.848, p < 0.001).Conclusions: Elevated Lp(a) concentrations and small apo(a) isoforms were significant risk factors for CAD strat-ification, and their effects on CAD risk were mediated by each other. Combined application of Lp(a) concentra-tions and apo(a) isoform with conventional risk factors could aid in the assessment and prediction of CAD.
引用
收藏
页码:2261 / 2270
页数:10
相关论文
共 50 条
  • [21] Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
    Hopewell, J. C.
    Seedorf, U.
    Farrall, M.
    Parish, S.
    Kyriakou, T.
    Goel, A.
    Hamsten, A.
    Collins, R.
    Watkins, H.
    Clarke, R.
    JOURNAL OF INTERNAL MEDICINE, 2014, 276 (03) : 260 - 268
  • [22] Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention
    Zhi-Gen Li
    Guang Li
    Ying-Ling Zhou
    Zhu-Jun Chen
    Jun-Qing Yang
    Ying Zhang
    Shuo Sun
    Shi-Long Zhong
    Lipids in Health and Disease, 12
  • [23] Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention
    Li, Zhi-Gen
    Li, Guang
    Zhou, Ying-Ling
    Chen, Zhu-Jun
    Yang, Jun-Qing
    Zhang, Ying
    Sun, Shuo
    Zhong, Shi-Long
    LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [24] CORONARY-ARTERY DISEASE IS ASSOCIATED WITH INCREASED LIPOPROTEIN(A) CONCENTRATIONS INDEPENDENT OF THE SIZE OF CIRCULATING APOLIPOPROTEIN(A) ISOFORMS
    FARRER, M
    GAME, FL
    ALBERS, CJ
    NEIL, HAW
    WINOCOUR, PH
    LAKER, MF
    ADAMS, PC
    GEORGE, K
    ALBERTI, KGMM
    ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (08): : 1272 - 1283
  • [25] Higher serum Lipoprotein(a) (Lp(a)) concentrations in chronic coronary artery disease are determined by apolipoprotein(a) (apo(a)) genotype and not coronary artery disease (CAD) phenotype.
    Piper, K
    Curtis, A
    Yallop, J
    Donnelly, T
    Barker, J
    Adams, PC
    Farrer, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A208 - A208
  • [26] THE ASSOCIATION OF LIPOPROTEIN(A), APOLIPOPROTEIN(A) PHENOTYPES AND AUTOANTIBODIES TO LIPOPROTEIN(A) WITH LOWER EXTREMITY ARTERY DISEASE
    Tmoyan, N. A.
    Afanasieva, O., I
    Klesareva, E. A.
    Afanasieva, M., I
    Razova, O. A.
    Ezhov, M., V
    Pokrovsky, S. N.
    KARDIOLOGIYA, 2018, 58 (12) : 45 - 51
  • [27] CORONARY-ARTERY DISEASE RISK PREDICTED BY PLASMA-CONCENTRATIONS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-B, AND LIPOPROTEIN(A) IN A GENERAL CHINESE POPULATION
    WU, JH
    KAO, JT
    WEN, MS
    WU, D
    CLINICAL CHEMISTRY, 1993, 39 (02) : 209 - 212
  • [28] ASSOCIATION OF LIPOPROTEIN(A) WITH CORONARY ARTERY DISEASE IN PERIPHERAL ARTERY DISEASE PATIENTS
    Tmoyan, N. A.
    Ezhov, M. V.
    Afanasieva, O. I.
    Klesareva, E. A.
    Afanasieva, M. I.
    Chubykina, U. V.
    Pokrovsky, S. N.
    ATHEROSCLEROSIS, 2022, 355 : E72 - E72
  • [29] Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease
    Katsouras, CS
    Karabina, SA
    Tambaki, AP
    Goudevenos, JA
    Michalis, LK
    Tsironis, LD
    Stroumbis, CS
    Elisaf, MS
    Sideris, DA
    Tselepis, AD
    JOURNAL OF CARDIOVASCULAR RISK, 2001, 8 (05): : 311 - 317
  • [30] LIPOPROTEIN (A) IN YOUNG CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH SEVERITY OF CORONARY ARTERY DISEASE
    Sawhney, J. P. S.
    Tyagi, K.
    Sharma, M. K.
    Madan, K.
    Vanani, J. K.
    Kandpal, B.
    Mehta, A.
    ATHEROSCLEROSIS, 2021, 331 : E117 - E117